Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03012282 · ClinicalTrials.gov registry record · NA
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer
A NA study, sponsored by University of Washington.
- Terminated
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03012282: Clinical Trial NA study, sponsored by University of Washington.
NCT03012282 is a NA study that was terminated before completion, run by University of Washington. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03012282, a NA study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well computed tomography (CT) perfusion images work in assessing treatment response in patients with pancreatic cancer. Analyzing specific measurements on the CT perfusion images may help doctors better determine how a tumor responds to chemotherapy and/or radiation therapy and may help guide treatment for patients with pancreatic cancer.
Primary Outcome
Assessed using logistic regression. Receiver operating characteristic (ROC) curve analysis will be used to examine the sensitivity and specificity of different thresholds for each parameter.
Interventions
- DIAGNOSTIC_TEST Computed Tomography Perfusion Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-06-22 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Why NCT03012282 stopped before completion
NCT03012282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Computed Tomography Perfusion Imaging is the first listed.
NCT03012282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03012282 about?
NCT03012282 is a clinical study titled "CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer". This pilot clinical trial studies how well computed tomography (CT) perfusion images work in assessing treatment response in patients with pancreatic cancer. Analyzing specific measurements on the CT perfusion images may help doctors better determine how a tumor responds to chemotherapy and/or radia...
What is the current status of trial NCT03012282?
This trial is currently terminated. It is a NA study. The enrollment target is 70 participants. The study started on 2017-06-22. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT03012282?
The interventions under investigation include: Computed Tomography Perfusion Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03012282?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03012282's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI